BBNX
Beta Bionics, Inc.
21.80$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -76.0% | -93.9% | -81.3% | -57.5% | -69.9% | -113.2% | -58.5% | -32.0% | -26.9% | -86.3% | -45.7% | -46.9% | |
| – | 6.5% | 4.4% | 3.8% | 3.7% | 2.6% | 3.4% | 2.8% | 2.5% | 2.9% | 3.6% | 3.5% | 3.1% | |
| 40.9% | 18.9% | 10.5% | 10.0% | 11.8% | 7.6% | 15.9% | 20.7% | 16.4% | 13.4% | 19.6% | 21.9% | 17.8% | |
| – | -6.8% | -37.7% | -17.9% | -10.2% | -15.9% | -36.7% | -6.5% | 1.2% | -4.2% | -29.7% | 1.6% | -7.3% | |
| 0.0% | 3.7% | 3.1% | 3.4% | 11.5% | 2.7% | 1.9% | 7.7% | 4.7% | 5.9% | 5.0% | 3.2% | 4.7% | |
| – | -833.6% | 59.1% | 21.9% | 91.2% | -145.1% | -1,015.5% | 26.6% | 34.8% | 2.0% | 79.1% | 84.1% | 49.5% | |
| – | 0.1% | 0.0% | -0.7% | -7.0% | 278.3% | 1,196.9% | 0.2% | 9.7% | 3.3% | 2.3% | 5.6% | 5.2% | |
| – | -909.5% | -34.7% | -60.1% | 26.7% | 63.4% | 68.2% | -31.8% | 12.5% | -21.5% | -5.0% | 44.1% | 7.8% | |
| – | -79.8% | -97.0% | -84.7% | -69.0% | -72.6% | -115.1% | -66.2% | -36.7% | -32.8% | -91.3% | -48.9% | -51.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.